This article outlines strategies insurers can use to mitigate their risks related to prescription opioid abuse by members, while addressing this serious public health problem.
Alan G. White, PhD
Advertisement
Articles by Alan G. White, PhD
This study evaluates the feasibility of using claims data to evaluate risk factors for prescription opioid abuse among patients in a privately insured population.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD
2
5 Ongoing Clinical Trials in Myeloproliferative Neoplasms
3
Defunding Co-Payment Assistance Disrupted nAMD Care
4
Aficamten Outperforms Metoprolol Across All Phases of Exercise in Obstructive HCM
5